Dexamethasone proves first life-saving drug in treatment of Coronavirus

Dexamethasone proves first life-saving drug in treatment of Coronavirus

Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone.[1] In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.

Read more
Taj Pharmaceuticals FDA Approvals of Oseltamivir Continues the Company Rise in the Generic Market

Taj Pharmaceuticals FDA Approvals of Oseltamivir Continues the Company Rise in the Generic Market

Oseltamivir Phosphate Capsules 75 mg – Manufacturer in India, Taj Pharma Oseltamivir Phosphate Capsules Supplier, Oseltamivir Phosphate Capsules Exporter Taj Pharma
Oseltamivir phosphate capsules, Oseltamivir Phosphate capsules manufacturers, Oseltamivir suppliers, Oseltamivir exporters in India, Get contact details & address of company manufacturing, Oseltamivir phosphate capsules
oseltamivir capsules 75 mg price, oseltamivir dose, oseltamivir interactions, oseltamivir warnings, tamiflu generic hallucinations, tamiflu generic side effects kids, how long do tamiflu side effects last
oseltamivir generic name, related to oseltamivir phosphate, oseltamivir phosphate cost, oseltamivir phosphate 75mg, oseltamivir interactions, oseltamivir warnings, oseltamivir mechanism of action, oseltamivir phosphate reviews, Oseltamivir generic, tamiflu generic

Read more
How voluntary licensing agreements are transforming HIV care

How voluntary licensing agreements are transforming HIV care

BARCELONA — In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organization funded primarily by Unitaid to increase access to medicines in lower-income countries, signed two voluntary licensing agreements. The agreements allowed generic manufacturers to produce and sell low-cost versions of the ViiV-developed HIV drug dolutegravir in all low- […]

Read more